/* mobile /* end mobile MEDDESKTOP: Mix Up Of Names Prevented Chinese Heparin Factory Inspection, FDA

Tuesday, February 19, 2008

Mix Up Of Names Prevented Chinese Heparin Factory Inspection, FDA

Chinese Factory Linked to Drug Heparin?

That we reported last week as well as Baxter recall, the factory has not been inspected by FDA due to mixup of names. FDA has mistakenly assumed that the factory was earlier inspected while it was not. The FDA's explanation, by Joseph Famulare, deputy director of compliance for the FDA's center for drug evaluation and research, comes amid questions about the safety of different types of goods made in China and the adequacy of the FDA's inspection procedures for drugs entering the U.S. from China.
source

tag: , ,

LinkWithin

Related Posts Widget for Blogs by LinkWithin